Ginkgo Bioworks Holdings (DNA) Other Operating Expenses (2020 - 2026)

Ginkgo Bioworks Holdings' Other Operating Expenses history runs 7 years deep, the most recent figure standing at -$7.1 million for Q1 2026.

• Quarterly Other Operating Expenses fell 54.1% year-over-year to -$7.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$12.6 million (down 278.27% YoY) and the FY2025 annual result came in at -$4.5 million, down 216.98% from the prior year.
• Other Operating Expenses was -$7.1 million for Q1 2026 at Ginkgo Bioworks Holdings, down from -$4.5 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $10.9 million in Q4 2024 and bottomed at -$7.1 million in Q1 2026.
• A 5-year average of $829250.0 and a median of $901000.0 in 2022 frame the typical range for Other Operating Expenses.
• Annual changes were most pronounced in 2024 — Other Operating Expenses jumped 11602.15% — and 2025, when it plunged 330.17%.
• Ginkgo Bioworks Holdings' Other Operating Expenses stood at $6.2 million in 2022, then tumbled by 98.49% to $93000.0 in 2023, then soared by 11602.15% to $10.9 million in 2024, then slumped by 141.6% to -$4.5 million in 2025, then sank by 57.87% to -$7.1 million in 2026.
• Business Quant data shows DNA's Other Operating Expenses at -$7.1 million in Q1 2026, -$4.5 million in Q4 2025, and -$896000.0 in Q2 2025.